Aspen Aerogels
ASPN
34 hedge funds and large institutions have $41.5M invested in Aspen Aerogels in 2019 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 14 increasing their positions, 7 reducing their positions, and 5 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 7
20% more capital invested
Capital invested by funds: $34.7M → $41.5M (+$6.82M)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0.81% less ownership
Funds ownership: 67.87% → 67.07% (-0.81%)
3% less funds holding
Funds holding: 35 → 34 (-1)
20% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 5
Top Buyers
Top Sellers
ASPN Hedge Fund Activity: Q1 2019 in Review
34 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Aspen Aerogels (ASPN) for Q1 2019, worth a combined $41.5M — up 20% from $34.7M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of ASPN and 4 opened new positions — a net loss of 1 holder — while 7 trimmed existing stakes and 14 added.
The largest buyer was Next Century Growth Investors, opening a new position worth an estimated $1.89M. The largest seller was Heartland Advisors, exiting entirely with an estimated $1.17M sold.
- 34 institutional investors held Aspen Aerogels (ASPN) as of Q1 2019, down from 35 in Q4 2018.
- Funds reported $41.5M of Aspen Aerogels stock for Q1 2019, up 20% quarter-over-quarter.
- 4 funds opened new Aspen Aerogels positions in Q1 2019 and 5 closed out, a net change of -1 holder.
- The largest Aspen Aerogels buyer in Q1 2019 was Next Century Growth Investors, an estimated $1.89M added.
- The largest Aspen Aerogels seller in Q1 2019 was Heartland Advisors, an estimated $1.17M sold.
Based on aggregated 13F filings for Q1 2019.